Article Information
History
- February 22, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Soumyadeep Sarkar1,
- Emily C. Elliott1,
- Hayden R. Henry1,
- Ivo Díaz Ludovico1,
- John T. Melchior1,2,
- Ashley Frazer-Abel3,
- Bobbie-Jo Webb-Robertson1,
- W. Sean Davidson2,
- V. Michael Holers3,
- Marian J. Rewers4,
- Thomas O. Metz1 and
- Ernesto S. Nakayasu1,*
- 1Biological Sciences Division, Pacific Northwest National Laboratory, Richland WA, USA
- 2Department of Pathology and Laboratory Medicine, Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
- 3Division of Rheumatology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
- 4Barbara Davis Center for Diabetes, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
- ↵*Correspondence: Ernesto S. Nakayasu, email: ernesto.nakayasu{at}pnnl.gov
Contributions: Concept and idea: MJR, ESN, & TOM; Systematic review of the literature: SS, ECE, & HRH; Analysis: All authors; Writing: SS, ECE, HRH, IDL, JTM, & ESN; All authors read and approved the final version of the manuscript.
Posted February 22, 2023.
Systematic review of type 1 diabetes biomarkers reveals regulation in circulating proteins related to complement, lipid metabolism, and immune response
